discount discount.....ResearchAarkstore Enterprise Molecular Diagnostics in Infectious Disease Testing
http://www.aarkstore.com/search/viewresults.asp?search=2012&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp?search=Markets&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp?search=Cancer%20&PubId=&pagenum=1 This TriMark Publications report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics-along with the development of microarray devices to measure analytes in the blood--has led to this revolutionary market development. Specifically, molecular diagnostics offers the power of advanced analytical techniques to diagnose infectious diseases. Whereas before, the detection of many infectious agents was slow and expensive due to reliance upon culturing methods, researchers are now at the cusp of overcoming such limitations via the use of nucleic acidmediated molecular diagnostics testing. The purpose of this report is to describe the emerging field of molecular diagnostics in infectious disease testing. The infectious disease space is the most dominant and profitable sector of molecular diagnostics. Topics covered in this study include: 1) the existing and emerging technologies in the field, 2) the U.S. and global market size for molecular diagnostic products and 3) the profiles of companies that are focusing on the molecular diagnostic sector. The research examines drivers and restraints for sales growth, market share and technical trends. In addition, an in-depth analysis of the competitive situation of prominent market venders is provided with five-year sales forecasts.
Table of Contents : 1. Overview 14 1.1 Statement of Report 14 1.2 About This Report 15 1.3 Scope of the Report 15 1.4 Objectives 17
1.5 Methodology 17 1.6 Executive Summary 19 2. Introduction to Molecular Diagnostics for Infectious Disease Testing 27 2.1 Molecular Diagnostics Testing and Opportunities in the Infectious Disease Sector 27 2.2 The Infectious Disease Problem 31 2.3 Impact of the Human Genome Project on Molecular Diagnostics 35 2.4 Opportunities for Molecular and Clinical Diagnostics 35 2.4.1 Companion Diagnostics 36 2.5 Development of Molecular Diagnostics Testing Markets 37 2.6 Target-based Gene Amplification 38 2.6.1 Polymerase Chain Reaction (PCR) 38 2.6.2 Real-time PCR (RT-PCR) 39 2.6.3 Nucleic Acid Sequence-based Amplification (NASBA) 39 2.6.4 Market Drivers and Restraints 46 2.6.4.1 Market Drivers 46 2.6.4.2 Market Restraints 46 2.6.5 Market and Technology Trends 46 2.6.5.1 Market Trends 46 2.6.5 2 Technology Trends 47 2.6.6 Strategic Recommendations 47 2.7 PCR Reagents for Clinical Diagnostics 48
3. Infectious Disease Diagnostics Molecular Testing Market 50 3.1 Market Overview 50 3.1.1 Overall Infectious Disease Market Analysis 53
3.2 NAT Molecular Diagnostics Market 65 3.3 Infectious Disease Molecular Diagnostic Testing Markets 66 3.3.1 HIV 66 3.3.1.1 Disease Background and Statistics 66 3.3.1.2 Measuring Viral Loads 74 3.3.1.3 Instruments and MD Reagents 75 3.3.1.4 Method Comparisons 81 For more information please visit link: http://www.aarkstore.com/reports/Molecular-Diagnostics-in-Infectious-Disease-Testing91895.html Neel Aarkstore Enterprise Phone:08149852585 Email:enquiry@aarkstore.com URL:www.aarkstore.com http://www.facebook.com/aarkstoreenterprise http://in.linkedin.com/in/aarkstore
Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing and PCR Markets Medical Imaging Markets Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets
Diabetes, Metabolic Syndrome and Cardiovascular Disease Catheter Markets Blood Glucose Testing and Diabetes Management Global Flow Cytometry Market U.S. Glucose Testing Markets High-Growth Diagnostic Testing Markets European Point of Care Diagnostic Testing Markets Disposable Syringe Markets Point of Care Diagnostic Testing World Markets Disposable Medical Supplies Markets Molecular Diagnostics in Infectious Disease Testing Companion Diagnostics in Personalized Medicine and Cancer Therapy World Glucose Self-Testing Markets Veterinary Health Markets Point of Care Diagnostic Testing Sector Trends Cardiac Marker Diagnostic Testing Markets Mass Spectroscopy for Clinical Laboratory Analysis Cardiac Rhythm Management Devices World Markets Picture Archiving and Communications Systems (PACS) Biomarker Technology Platforms for Cancer Diagnoses and Therapies Cancer Diagnostic Testing World Markets Positron Emission Tomography (PET) Markets Molecular Diagnostics Markets Molecular Diagnostics in Cancer Testing Drugs of Abuse Testing Markets Ultrasound Markets Nuclear Cardiology Markets Medical Imaging Bundle Cancer Vaccines Markets
European Medical Imaging Markets Respiratory Therapeutics and Devices Markets Diagnostics Bundle Mammography World Markets
India's In Vitro Diagnostic Testing Industry Orthopedics Markets Cell-Based Assays for Drug Discovery Cytology and HPV Testing World Markets Clinical Chemistry Analyzers Clinical Immunoanalyzer Markets Microscopy Markets Automated Microbial Testing Markets Anti-Infective Drugs Markets Plastic Surgery Markets